Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Polaris AI Pharma Corp. (041910:KRX), powered by AI.
Polaris AI Pharma Corp. is currently trading at ₩5,320. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Polaris AI Pharma Corp. on Alpha Lenz.
Polaris AI Pharma Corp.'s P/E ratio is 11.5.
“Polaris AI Pharma Corp. trades at a P/E of 11.5 (undervalued) with modest ROE of 4.7%.”
Ask for details →Polaris AI Pharma Corp., a biotechnology company, is at the forefront of integrating artificial intelligence with pharmaceutical research and development. Its primary purpose is to enhance drug discovery and streamline development processes, aiming to bring effective treatments to market more efficiently. Utilizing cutting-edge AI algorithms, Polaris AI Pharma Corp. manages vast datasets to identify potential drug candidates and predict their interactions and efficacy with unprecedented accuracy. The company's work significantly impacts sectors such as oncology, neurology, and cardiovascular diseases, addressing complex medical challenges with innovative solutions. As a player in the biotech industry, Polaris AI Pharma Corp. plays a vital role in advancing medical technology and paving the way for personalized medicine, ultimately seeking to improve patient outcomes on a global scale.
“Polaris AI Pharma Corp. trades at a P/E of 11.5 (undervalued) with modest ROE of 4.7%.”
Ask for details →Polaris AI Pharma Corp. (ticker: 041910) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $70.7B.
The current price is ₩5,320 with a P/E ratio of 11.47x and P/B of 0.52x.
ROE is 4.66% and operating margin is 5.74%. Annual revenue is $55.5B.